Radioisotope developer Isonics of Golden, CO, has signed an agreement with Central Radiopharmaceutical Services (CRS) of Buffalo, NY, for the joint production and marketing of indium-111.
CRS will provide irradiation facilities and expertise, as well as chemical syntheses using Isonics-provided methodologies, the company said. Initial commercial quantities of indium-111 are expected in the fourth quarter this year.
The firms have been collaborating on the development of new manufacturing methods over the past six months, according to Isonics.
By AuntMinnie.com staff writers
June 15, 2005
Related Reading
Isonics raises $2.2 million to expand radioisotope line, January 29, 2004
Copyright © 2005 AuntMinnie.com
